Blackstone Inc’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,500
Closed -$377K 189
2022
Q4
$377K Hold
37,500
﹤0.01% 140
2022
Q3
$368K Hold
37,500
﹤0.01% 171
2022
Q2
$367K Buy
+37,500
New +$367K ﹤0.01% 192
2022
Q1
Sell
-250,000
Closed -$2.44M 336
2021
Q4
$2.44M Hold
250,000
0.01% 286
2021
Q3
$2.42M Hold
250,000
0.01% 334
2021
Q2
$2.44M Buy
+250,000
New +$2.45M 0.01% 335

Other funds holding AONC

Blackstone Inc's AONC Position: Q1 2023 in Review

Blackstone Inc sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 37,500 shares — an estimated $377K sold.

Blackstone Inc first reported a position in AONC in Q2 2021 and held it in 6 quarters. The position peaked at $2.44M in Q4 2021. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Blackstone Inc reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Blackstone Inc sold 37,500 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $377K.
  • Blackstone Inc first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Blackstone Inc's American Oncology Network, Inc. Class A Common Stock position peaked at $2.44M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Blackstone Inc's 13F filing for Q1 2023, filed 15 May 2023.